Research Appraisalother

Development, Evaluation and Application of a Multi-Representation Fusion Model for Accurate Prediction of Per- and Polyfluoroalkyl Substance (PFAS) Binding to Plasma Proteins

Journal of chemical information and modelingHan, Junshan, Song, Xinyu, Yi, Duoyun et al.27 Apr 2026DOI

Clinical Snapshot

75CEBM
Evidence: Moderateother

PICO Framework

P — PopulationPer- and polyfluoroalkyl substances (PFAS) - a diverse class of synthetic chemicals
I — InterventionMURNet multi-representation fusion network model integrating chemical descriptors, 2D molecular graphs, and molecular fingerprints
C — ComparatorState-of-the-art baseline models and traditional experimental approaches
O — OutcomesPrediction accuracy of PFAS-plasma protein binding, particularly human serum albumin (HSA) binding affinity

Bottom Line

This computational study presents MURNet, a novel multi-representation fusion model for predicting PFAS binding to plasma proteins. The approach integrates chemical descriptors, molecular graphs, and fingerprints to overcome limitations of single-representation methods. While the multi-modal strategy appears promising and addresses an important public health concern, the abstract lacks crucial quantitative validation metrics. The model's ability to predict binding for PFAS homologues suggests potential utility in regulatory screening, particularly relevant for Australian contexts given ongoing PFAS contamination concerns. However, clinicians should await full publication with detailed validation data, performance metrics, and external validation results before considering this tool for risk assessment applications. The computational approach offers advantages over expensive experimental methods but requires rigorous validation to ensure clinical utility.

Evidence: Moderate

Key Findings

  • P Value: Not reported in abstract

  • Effect Size: Described as 'optimal comprehensive performance' compared to baseline models (specific metrics not provided)

  • Primary Outcome: Prediction accuracy of PFAS-plasma protein binding using MURNet model

  • Nnt Or Sensitivity: Tanimoto similarity applicability domain analysis demonstrates reliable prediction capability for PFAS homologues

  • Confidence Interval: Not reported in abstract

Clinical Application

High feasibility as computational tool requiring only molecular structure input, cost-effective compared to experimental approaches Highly relevant given Australia's PFAS contamination issues around military bases and industrial sites. Could support TGA chemical assessment processes and inform NHMRC drinking water guidelines Relevant to populations exposed to PFAS contamination, particularly useful for regulatory agencies and toxicologists assessing health risks

Abstract

Per- and polyfluoroalkyl substances (PFAS) constitute a large and structurally diverse class of man-made chemicals. Their strong carbon-fluorine (C-F) bonds confer high environmental persistence, bioaccumulation, and various associated toxicities. As amphiphilic compounds, most PFAS bind to proteins and accumulate in protein-rich tissues, with such bioaccumulation exerting significant adverse impacts on human health. Accurate evaluation of the binding status between PFAS and proteins constitutes an essential step in health risk assessment. Traditional experiments and certain modeling approaches for analyzing PFAS bioaccumulation suffer from drawbacks such as time-consuming processes, high costs, or inadequate capture of molecular structural information, while existing machine learning-based prediction methods rely on single molecular representation, making it difficult to comprehensively encode the structural information on PFAS. Here, we propose MURNet, a multirepresentation fusion network model integrating chemical descriptors, 2D molecular graphs, and molecular fingerprints to predict PFAS-plasma protein binding. Compared with the state-of-the-art baseline models, MURNet achieves the optimal comprehensive performance. The multirepresentation fusion strategy generates higher-quality molecular features. Tanimoto similarity applicability domain analysis demonstrates MURNet's capability to reliably predict PFAS homologues. Case studies reveal the effectiveness of MURNet in screening PFAS with potential binding affinity to human serum albumin (HSA).

References

  1. 1.Han, J., Song, X., Yi, D., Zhang, Y., Chu, Y., Wei, Y., He, S., & Bo, X. (2026). Development, evaluation and application of a multi-representation fusion model for accurate prediction of per- and polyfluoroalkyl substance (PFAS) binding to plasma proteins. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.5c03060
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service